522 related articles for article (PubMed ID: 28260426)
1. Borderline Changes on Dysfunctional Renal Allograft Biopsies: Clinical Relevance in a Living Related Renal Transplant Setting.
Mubarak M; Shakeel S; Abbas K; Aziz T; Zafar MN; Naqvi SA; Rizvi SA
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):24-27. PubMed ID: 28260426
[TBL] [Abstract][Full Text] [Related]
2. Significance of the Banff borderline biopsy.
Schweitzer EJ; Drachenberg CB; Anderson L; Papadimetriou JC; Kuo PC; Johnson LB; Klassen DK; Hoehn-Saric E; Weir MR; Bartlett ST
Am J Kidney Dis; 1996 Oct; 28(4):585-8. PubMed ID: 8840950
[TBL] [Abstract][Full Text] [Related]
3. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
[TBL] [Abstract][Full Text] [Related]
4. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies.
Meehan SM; Siegel CT; Aronson AJ; Bartosh SM; Thistlethwaite JR; Woodle ES; Haas M
J Am Soc Nephrol; 1999 Aug; 10(8):1806-14. PubMed ID: 10446950
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Indication Biopsies ≥5 Years After Kidney Transplant: A Single-Center Experience.
Tatar E; Simsek C; Tasli F; Cayhan VK; Karatas M; Uslu A
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):265-268. PubMed ID: 28260483
[TBL] [Abstract][Full Text] [Related]
6. Impact of Banff borderline acute rejection among renal allograft recipients.
Matoza JR; Danguilan RA; Chicano S
Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
[TBL] [Abstract][Full Text] [Related]
7. Immunohistopathologic Characterization of Plasma Cell-Rich Acute Rejection in Living-Related Renal Transplant Recipients.
Mubarak M; Abbas K; Zafar MN; Aziz T
Exp Clin Transplant; 2017 Oct; 15(5):516-520. PubMed ID: 28467296
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies.
Emovon OE; King JA; Smith SR; Op't Holt C; McDonald F; Howell DN; Browne BJ
Clin Nephrol; 2003 May; 59(5):367-72. PubMed ID: 12779099
[TBL] [Abstract][Full Text] [Related]
9. Four-Year Analyses of Renal Graft Biopsies: A Single-Center Pathology Experience.
Canpolat T; Ozdemir BH; Torun D; Caliskan K; Haberal M
Exp Clin Transplant; 2017 Apr; 15(2):171-178. PubMed ID: 27099951
[TBL] [Abstract][Full Text] [Related]
10. Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
Aoun B; Decramer S; Vitkevic R; Wannous H; Bandin F; Azema C; Callard P; Brocheriou I; Ulinski T
Pediatr Nephrol; 2013 Mar; 28(3):493-8. PubMed ID: 23111894
[TBL] [Abstract][Full Text] [Related]
11. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
Zhao X; Huang G; Randhawa S; Zeng G; Lunz J; Randhawa P
Transplantation; 2017 Feb; 101(2):395-401. PubMed ID: 26901079
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema.
Saad R; Gritsch HA; Shapiro R; Jordan M; Vivas C; Scantlebury V; Demetris AJ; Randhawa PS
Transplantation; 1997 Oct; 64(7):992-5. PubMed ID: 9381547
[TBL] [Abstract][Full Text] [Related]
13. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
[TBL] [Abstract][Full Text] [Related]
14. Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss.
Muorah MR; Brogan PA; Sebire NJ; Trompeter RS; Marks SD
Pediatr Transplant; 2009 Mar; 13(2):217-22. PubMed ID: 18433412
[TBL] [Abstract][Full Text] [Related]
15. Renal medullary changes in renal allograft recipients with raised serum creatinine.
Sis B; Sarioglu S; Celik A; Kasap B; Yildiz S; Kavukcu S; Gulay H; Camsari T
J Clin Pathol; 2006 Apr; 59(4):377-81. PubMed ID: 16461569
[TBL] [Abstract][Full Text] [Related]
16. Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor.
Abbas K; Mubarak M; Zafar MN; Musharraf W; Imam M; Aziz T; Rizvi AH
Exp Clin Transplant; 2019 Feb; 17(1):42-46. PubMed ID: 29534661
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study.
Ganesh K; Jayaram JK; Thomas RM; Abraham TT; Kumar JS; Simon SS; Abraham MA
Transplant Proc; 2024; 56(1):97-104. PubMed ID: 38216361
[TBL] [Abstract][Full Text] [Related]
18. Immuno-histological assessment of sub-clinical acute and borderline rejection in renal allograft recipients: Data from a transplant center in India.
Badwal S; Kumar A; Hooda AK; Varma PP
Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1232-40. PubMed ID: 26586064
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of patients with Banff borderline changes in renal allograft biopsies.
El-Agroudy AE; Wafa EW; Abbas TM; El-Husseini A; Gheith OA; El-Baz M; Ghoneim MA
Exp Clin Transplant; 2009 Dec; 7(4):228-32. PubMed ID: 20353372
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological analyses of chronic vascular rejection after kidney transplantation.
Shimizu T; Toma H; Shibahara R; Tsunoyama K; Izuka J; Nozaki T; Ishida H; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():20-5. PubMed ID: 26031581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
